William J. Link PhD - 22 Jun 2023 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TARS	Stock Option (right to buy)	Award	$0	+5,000		$0.000000	5,000	22 Jun 2023	Common Stock	5,000	$17.99	Direct	F1
transaction	TARS	Restricted Stock Units	Award	$0	+3,350		$0.000000	3,350	22 Jun 2023	Common Stock	3,350		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
F2	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
F3	RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.